Product Information
SEROQUEL 50 MG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $6.0917 per EA under NDC 00310027810. Its NADAC has been published 176 times since Nov 28, 2013.
FDA first approved this application on Sep 26, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the quetiapine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310027810
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/22/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA020639FDA Approved
9/26/1997
TE Code
AB
On Market Since
2/13/2006
Pharmacological Classes
Price Statistics
The NADAC for SEROQUEL 50 MG TABLET has been published 176 times since Nov 28, 2013, and over the history we have for it it has declined 2.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.0917 per EA |
|---|---|
| All-time high | $6.2407 (Dec 11, 2013) |
| All-time low | $6.0823 (Apr 17, 2024) |
| 52-week high | $6.1136 |
| 52-week low | $6.0896 |
| Median price | $6.1136 |
| Average price | $6.1321 |
| Largest weekly change | -1.6% (Apr 17, 2024) |
| Weeks tracked | 176 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
0.0%
6M
-0.1%
1Y
-0.4%
3Y
-1.4%
5Y
-1.4%
All
-2.4%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SEROQUEL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEROQUEL 50 MG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $6.0917 per EA (NDC 00310027810), effective Jul 1, 2026.
How has the price of SEROQUEL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEROQUEL 50 MG TABLET has declined 2.4%. It has been tracked across 176 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SEROQUEL 50 MG TABLET?
Since Nov 28, 2013, the NADAC for SEROQUEL 50 MG TABLET has ranged from a low of $6.0823 (Apr 17, 2024) to a high of $6.2407 (Dec 11, 2013), with a median of $6.1136 per EA.
Are there cheaper alternatives to SEROQUEL 50 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 50 MG TAB, is $0.0282 per EA — about 99% below SEROQUEL 50 MG TABLET.
Who manufactures SEROQUEL 50 MG TABLET?
SEROQUEL 50 MG TABLET (NDC 00310027810) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.